MOREPENLABMorepen Laboratories

₹48.2+0.10%

Market Cap

₹2,641.68 Cr

Stock P/E

28.53

ROCE

15.48%

ROE

11.78%

Book Value

₹21.31

Financials

YoY Net Sales

EPS Growth

Operating Margin

No recent news available for this stock.

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

POSITIVES

•
Export-led growth with stronger dollar revenue diversification.
•
Market leadership and integrated medical devices manufacturing enhancing competitive moat.

NEGATIVES

•
Near-term profitability softness due to API price pressures and last-quarter weakness.
•
Significant API price erosion with volume gains not fully offsetting ASP declines.

Peer comparison data is not available for this stock.